Cellectis S.A.
CMVLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.08 | -0.03 | 0.00 | -0.05 |
| FCF Yield | -1.06% | -8.46% | -14.02% | -1.19% |
| EV / EBITDA | 31.94 | -9.62 | -7.92 | 7.98 |
| Quality | ||||
| ROIC | 3.97% | -4.81% | -6.61% | -4.26% |
| Gross Margin | 93.30% | 85.50% | 81.09% | 100.00% |
| Cash Conversion Ratio | -2.67 | 0.43 | 0.95 | -0.01 |
| Growth | ||||
| Revenue 3-Year CAGR | 65.86% | 50.56% | 39.20% | 29.27% |
| Free Cash Flow Growth | 74.07% | 39.53% | -879.63% | 72.99% |
| Safety | ||||
| Net Debt / EBITDA | -1.90 | -2.10 | 3.18 | -4.20 |
| Interest Coverage | 3.82 | -4.67 | -7.42 | -6.39 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -593.96 | -492.26 | -553.07 | 163.04 |